CoChat

Economic Cost of Age-Related Macular Degeneration: A Review of Recent Research

Ke, Kathleen M, Chakravarthy, Usha, O???Neill, Ciaran · 2006 · Drugs & Aging

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

As the population of most developed countries ages so the prevalence of diseases such as age-related macular degeneration (AMD) are likely to increase. To facilitate planning and informed debate regarding making provisions for this disease it is important that we have a clear understanding of the economic impact of visual impairment associated with AMD. In this paper we assess the state of current knowledge based on a review of published evidence in scientific journals. Based on our assessment of the evidence we argue that the paucity of research studies on the subject and wide variation in estimates produced from the few studies available make it difficult to assess with confidence the likely average direct cost-of-illness associated with AMD. We further argue that significant gaps in our understanding of the costs of AMD (particularly in respect of indirect costs) also exist. Current research should be augmented by more comprehensive studies.

Overview

Integrity signals

Registry

Crossref · 10.2165/00002512-200623030-00004

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 3

  1. Resnikoff, 2004, Bull World Health Organ, 82, 844
  2. Husereau, 2002, Ottawa (ON): Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 31, 40
  3. Brown, 1999, Trans Am Ophthalmol Soc, 97, 473

Cited by

See all 12

Metadata

Authors
Ke, K. M., Chakravarthy, U., & O???Neill, C.
Affiliations
Queen's University Belfast (GB)
Venue
Drugs & Aging
Published
2006
Volume
23
Issue
3
Pages
217-225
ISSN
1170-229X (ISSN-L)
OpenAlex
W2017811645
Cited by
12
References
34
Citations by year
2025: 2 · 2024: 2 · 2022: 1 · 2021: 1 · 2013: 2
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs & Aging (publishedVersion)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
Keywords
age-related macular degeneration, economic cost of illness, direct costs, indirect costs, visual impairment, cost estimate
MeSH terms
Aged, Aging, Cost-Benefit Analysis, Costs and Cost Analysis, Health Planning, Humans, Macular Degeneration, Databases, Bibliographic, Health Care Costs, Cost of Illness, Models, Economic, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Economic Cost of Age-Related Macular Degeneration: A Review of Recent Research. https://app.cochat.ai/papers/10.2165/00002512-200623030-00004
The paper
Ke, K. M., Chakravarthy, U., & O???Neill, C. (2006). Economic Cost of Age-Related Macular Degeneration: A Review of Recent Research. Drugs & Aging. https://doi.org/10.2165/00002512-200623030-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.